We are live on ! Find out more
SM

SB Management Portfolio holdings

AUM $516M
1-Year Est. Return 40.71%
This Fund
S&P 500
This Quarter Est. Return
+8.63%
1 Year Est. Return
-40.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.5B
AUM Growth
-$7.02B
Cap. Flow
-$7.74B
Cap. Flow %
-91.01%
Top 10 Hldgs %
94.15%
Holding
49
New
17
Increased
5
Reduced
4
Closed
16

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 66.47%
2 Healthcare 10.7%
3 Financials 10.69%
4 Technology 10.16%
5 Communication Services 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMIIU
26
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$5.53M 0.07%
411,151
-2,320,849
-85% -$30.9M
BTNB
27
DELISTED
Bridgetown 2 Holdings Limited Class A Ordinary Shares
BTNB
$5.1M 0.06%
500,000
EQRXW
28
CALL
DELISTED
EQRx, Inc. Warrant
EQRXW
$2.06M 0.02%
+800,000
New +$2.12M
HERAW
29
CALL
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$1.65M 0.02%
+1,250,000
New +$1.35M
CPUH.WS
30
CALL
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$1.51M 0.02%
+1,000,000
New +$1.22M
PACXW
31
CALL
DELISTED
Pioneer Merger Corp. Warrant
PACXW
$1.48M 0.02%
+916,666
New +$1.06M
REVHW
32
CALL
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$846K 0.01%
+600,000
New +$764K
FTAAW
33
CALL
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
$750K 0.01%
+500,000
New +$529K
ADBE icon
34
Adobe
ADBE
$90.9B
-20,048
Closed -$9.53M
CRM icon
35
Salesforce
CRM
$139B
-1,816,709
Closed -$385M
FDMT icon
36
4D Molecular Therapeutics
FDMT
$580M
-347,910
Closed -$15.1M
GOOG icon
37
Alphabet (Google) Class C
GOOG
$4.38T
-5,555,000
Closed -$575M
META icon
38
Meta Platforms (Facebook)
META
$1.64T
-10,802,959
Closed -$3.18B
MSFT icon
39
Microsoft
MSFT
$2.92T
-4,368,656
Closed -$1.03B
NFLX icon
40
Netflix
NFLX
$283B
-7,313,750
Closed -$382M
WGSWW
41
GeneDx Holdings Warrant
WGSWW
$20K
-2,500,000
Closed -$37.2M
CPUH.U
42
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
-4,000,000
Closed -$40.4M
HERAU
43
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
-5,000,000
Closed -$50M
FTAAU
44
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
-2,000,000
Closed -$20.1M
PACX
45
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
-2,750,000
Closed -$26.7M
PACXW
46
DELISTED
Pioneer Merger Corp. Warrant
PACXW
-916,666
Closed -$1.06M
REVHU
47
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
-3,000,000
Closed -$30.1M
LCIDW
48
DELISTED
Lucid Group, Inc. Warrant
LCIDW
-3,333,333
Closed -$77.3M
TBA
49
DELISTED
Thoma Bravo Advantage
TBA
-2,500,000
Closed -$26.1M

Similar funds

SB Management's Q2 2021 Portfolio in Review

As of Q2 2021, SB Management held 49 positions worth $8.5B, down 45% from $15.5B the previous quarter. Its ten largest holdings account for 94% of the portfolio.

SB Management withdrew a net $7.74B in Q2 2021, closing 16 positions and reducing 4 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $3.18B position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 66% of assets, up from 40% a quarter earlier, followed by Healthcare and Financials.

Against the trend, SB Management opened a new position in Lyell Immunopharma worth $56.8M.

  • SB Management's largest Q2 2021 buy was Lyell Immunopharma: 175,000 shares worth $56.8M.
  • SB Management added most to AbCellera Biologics in Q2 2021, an estimated $55.2M increase.
  • SB Management's biggest Q2 2021 reduction was Amazon, cutting an estimated $1.21B.
  • SB Management fully exited Meta Platforms (Facebook) in Q2 2021, selling an estimated $3.18B.
  • SB Management's ten largest holdings make up 94% of its $8.5B portfolio in Q2 2021.
  • SB Management opened 17 new positions and closed 16 in Q2 2021.
  • SB Management's portfolio value fell 45% quarter-over-quarter to $8.5B.

Based on SB Management's 13F filing for Q2 2021, filed 16 Aug 2021.